In the early stages of breast cancer, TGF-β1 shows anti-tumor activity by mediating growth arrest and cancer cell apoptosis; however, in the late stages, TGF-β1 enhances the malignancy of breast cancer cells (55). This evidence concerns the gene TGFB1 and breast carcinoma.